Biblio

Author Title [ Type(Desc)] Year
Filters: Author is Ahmadi, Majid  [Clear All Filters]
Journal Article
Budi HSetia, Izadi S, Timoshin A, Asl SHeydarzade, Beyzai B, Ghaderpour A, Alian F, Eshaghi FSadat, Mousavi SMahboubeh, Rafiee B, et al. Blockade of HIF-1α and STAT3 by hyaluronate-conjugated TAT-chitosan-SPION nanoparticles loaded with siRNA molecules prevents tumor growth. Nanomedicine. 2021:102373.
Shabgah AGowhari, Al-Qaim ZHaleem, Markov A, Yumashev AValerievic, Ezzatifar F, Ahmadi M, Gheibihayat SMohammad, Navashenaq JGholizadeh. Chemokine CXCL14; a double-edged sword in cancer development. Int Immunopharmacol. 2021;97:107681.
Shabgah AGowhari, Abdelbasset WKamal, Rahman HSulaiman, Bokov DO, Suksatan W, Thangavelu L, Ahmadi M, Malekahmadi M, Gheibihayat SMohammad, Navashenaq JGholizadeh. A comprehensive review of IL-26 to pave a new way for a profound understanding of the pathobiology of cancer, inflammatory diseases, and infections. Immunology. 2021.
Ahmadi M, Yousefi M, Abbaspour-Aghdam S, Dolati S, Aghebati-Maleki L, Eghbal-Fard S, Khabbazi A, Rostamzadeh D, Alipour S, Shabani M, et al. Disturbed Th17/Treg balance, cytokines, and miRNAs in peripheral blood of patients with Behcet's disease. J Cell Physiol. 2018.
Danaii S, Ghorbani F, Ahmadi M, Abbaszadeh H, Koushaeian L, Soltani-Zangbar MSadegh, Mehdizadeh A, Hojjat-Farsangi M, Kafil HSamadi, Aghebati-Maleki L, et al. IL-10-producing B cells play important role in the pathogenesis of recurrent pregnancy loss. Int Immunopharmacol. 2020;87:106806.
Eghbal-Fard S, Yousefi M, Heydarlou H, Ahmadi M, Taghavi S, Movasaghpour A, Jadidi-Niaragh F, Yousefi B, Dolati S, Hojjat-Farsangi M, et al. The imbalance of Th17/Treg axis involved in the pathogenesis of preeclampsia. J Cell Physiol. 2018.
Gharibi T, Ahmadi M, Seyfizadeh N, Jadidi-Niaragh F, Yousefi M. Immunomodulatory characteristics of mesenchymal stem cells and their role in the treatment of Multiple Sclerosis. Cell Immunol. 2015;293(2):113-121.
Jafarzadeh S, Ahmadi M, Dolati S, Aghebati-Maleki L, Eghbal-Fard S, Kamrani A, Behrad B, Roshangar L, Jadidi-Niaragh F, Yousefi B, et al. Intravenous immunoglobulin G treatment increases live birth rate in women with recurrent miscarriage and modulates regulatory and exhausted regulatory T cells frequency and function. J Cell Biochem. 2018.
Dauletova M, Hafsan H, Mahhengam N, Zekiy AOlegovna, Ahmadi M, Siahmansouri H. Mesenchymal stem cell alongside exosomes as a novel cell-based therapy for COVID-19: A review study. Clin Immunol. 2021:108712.
Rostamzadeh D, Yousefi M, Haghshenas MReza, Ahmadi M, Dolati S, Babaloo Z. mTOR Signaling pathway as a master regulator of memory CD8 T-cells, Th17, and NK cells development and their functional properties. J Cell Physiol. 2019.
Hajialilo M, Dolati S, Abdolmohammadi-Vahid S, Ahmadi M, Kamrani A, Eghbal-Fard S, Ghassembaglou A, Valizadeh A, Shenas MHossein Mu, Aghebati-Maleki L, et al. Nanocurcumin: A novel strategy in treating ankylosing spondylitis by modulating Th17 cells frequency and function. J Cell Biochem. 2019.
Tahmasebi S, Saeed BQubais, Temirgalieva E, Yumashev AValerievic, El-Esawi MA, Navashenaq JGholizadeh, Valizadeh H, Sadeghi A, Aslani S, Yousefi M, et al. Nanocurcumin improves Treg cell responses in patients with mild and severe SARS-CoV2. Life Sci. 2021:119437.
Valizadeh H, Abdolmohammadi-Vahid S, Danshina S, Gencer MZiya, Ammari A, Sadeghi A, Roshangar L, Aslani S, Esmaeilzadeh A, Ghaebi M, et al. Nano-curcumin therapy, a promising method in modulating inflammatory cytokines in COVID-19 patients. Int Immunopharmacol. 2020;89(Pt B):107088.
Ahmadi M, Ghaebi M, Abdolmohammadi-Vahid S, Abbaspour-Aghdam S, Hamdi K, Abdollahi-Fard S, Danaii S, Mosapour P, Koushaeian L, Dolati S, et al. NK cell frequency and cytotoxicity in correlation to pregnancy outcome and response to IVIG therapy among women with recurrent pregnancy loss. J Cell Physiol. 2018.
Aravindhan S, Younus LA, Lafta MHadi, Alexander M, Enina YIvanovna, Yushchenkо NA, Thangavelu L, Mostafavi SMojtaba, Pokrovskii MV, Ahmadi M. P53-long noncoding RNA regulatory network in cancer development. Cell Biol Int. 2021.
Kamrani A, Alipourfard I, Ahmadi-Khiavi H, Yousefi M, Rostamzadeh D, Izadi M, Ahmadi M. The role of epigenetic changes in preeclampsia. Biofactors. 2019.
Koushaeian L, Ghorbani F, Ahmadi M, Eghbal-Fard S, Zamani M, Danaii S, Yousefi B, Jadidi-Niaragh F, Hamdi K, Yousefi M. The role of IL-10-producing B cells in Repeated Implantation Failure patients with cellular immune abnormalities. Immunol Lett. 2019.
Shabgah AGowhari, Salmaninejad A, Thangavelu L, Alexander M, Yumashev AValerievic, Goleij P, Hedayati-Moghadam M, Mohammadi H, Ahmadi M, Navashenaq JGholizadeh. The role of non-coding genome in the behavior of infiltrated myeloid-derived suppressor cells in tumor microenvironment; a perspective and state-of-the-art in cancer targeted therapy. Prog Biophys Mol Biol. 2020.
Kiani FKaroon, Izadi S, Dezfouli EAnsari, Ebrahimi F, Mohammadi M, Chalajour H, Bulus MMortazavi, Esfahani MNasr, Karpisheh V, Khesht AMahmoud Sa, et al. Simultaneous silencing of A2aR and PD-1 as immune checkpoints by siRNA-loaded nanoparticles enhances the immunotherapeutic potential of dendritic cell vaccine in tumor experimental models. Life Sci. 2021:120166.
Ahmadi M, Abdolmohamadi-Vahid S, Ghaebi M, Dolati S, Abbaspour-Aghdam S, Danaii S, Berjis K, Madadi-Javid R, Nouri Z, Siahmansouri H, et al. Sirolimus as a new drug to treat RIF patients with elevated Th17/Treg ratio: A double-blind, phase II randomized clinical trial. Int Immunopharmacol. 2019;74:105730.
Ghaebi M, Abdolmohammadi-Vahid S, Ahmadi M, Eghbal-Fard S, Dolati S, Nouri M, Talebi M, Hamdi K, Marofi F, Aghebati-Maleki L, et al. T cell Subsets in Peripheral Blood of Women with Recurrent Implantation Failure. J Reprod Immunol. 2018;131:21-29.
Vakili-Samiani S, Jalil ATurki, Abdelbasset WKamal, Yumashev AValerievic, Karpisheh V, Jalali P, Adibfar S, Ahmadi M, Feizi AAli Hossei, Jadidi-Niaragh F. Targeting Wee1 kinase as a therapeutic approach in Hematological Malignancies. DNA Repair (Amst). 2021;107:103203.